Viral Hepatitis in Asia and the Pacific

Towards Elimination as a Public Health Threat
Erscheinungsjahr 2025
ISBN: 978-0-443-23629-7
Verlag: Elsevier Science

Buch, Englisch, 282 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination.

Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.

Autoren/Hrsg.

Sun, Jing

Chan, Polin

Chee, Yoke Ling

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat

Chapter 1 Epidemiology and response to viral hepatitis in Asia and the Pacific regions
Polin Chan, Tiara Mahatmi Nisa, Mohamed Amine Ghrabi, Kiyohiko Izumi, Amit Goel, Bharat Bhushan Rewari

Chapter 2 Towards elimination of viral hepatitis B and C in Australia
Jisoo A. Kwon, David C. Boettiger, David Newby

Chapter 3 Central pooled procurement and price negotiation: China’s strategies for affordable antiviral treatment of hepatitis B and C
Yihan Fu, Zhuoran Ma, Zhitao Wang, Shiyang Liu, Zhongdan Chen, Changsong Jiang, Jing Sun

Chapter 4 Efforts towards elimination of viral hepatitis in India
Ajeet Singh Bhadoria, Vineet Kumar Pathak, Pallav Bhattacharya, Pritam Roy, Gagandeep Grover, Pragya Pandey

Chapter 5 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in Kiribati
Thomas Russell, David Hilmers, Caroline Lee, Alice Lee

Chapter 6 Government-led initiatives: a journey of enhancing hepatitis C treatment accessibility in Malaysia
Muhammad Radzi Abu Hassan, Huan Keat Chan, Han Yang Chung, Fazidah Binti Yuswan

Chapter 7 Viral hepatitis elimination in Mongolia
Gereltuya Dorj, Baatarkhuu Oidov, Gantuya Dorj, Undram Lkhagvaa, Nick Walsh, Amarjargal Choijoo, Unenbat Gurbadam, Javkhlan Jargalsaikhan, Baasandorj Erdenetsetseg

Chapter 8 Hepatitis B immunization
Xi Li, Sigrun Roesel

Chapter 9 South-South partnerships in developing affordable DAAs for low- and middle-income countries
Tilak Ramanaidu, Jean-Michel Piedagnel, Han Yang Chung, Wing Loong Cheong

Chapter 10 The ‘how’ of shifting a global paradigm: from dual to triple elimination of HIV, syphilis and viral hepatitis B

Polin Chan, Hui Zheng, Ailing Wang, Fuzhen Wang, Jinlin Hou, Zhihua Liu, Jidong Jia, Lai Wei, Yu Wang, Timothy Hallett, Shevanthi Nayagam, Xiaoyan Wang, Qian Wang, Fuqiang Cui, Daniel Low-Beer, Philippa Easterbrook, Zhuang Hui, Lawrence Everett Rodewald

Über Autor(innen)

Sun, Jing
Dr. Sun is the Professor for Pharmaceutical Policy of the Chinese Academy of Medical Sciences and Peking Union Medical College. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. She received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands, MSc. of International Health Policy from London School of Economics of the UK, and Bachelor of Pharmaceutical Chemistry from Peking Medical University of China.

Chee, Yoke Ling
Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).

Chan, Polin
Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women's health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine.